On March 20. 2025 (local time), the 2025 DCAT Week concluded successfully in New York, USA. As a global CDMO service provider, Laviana Pharma once again became the focus of the industry with its outstanding technological strength and forward-looking strategic layout. This global event, hosted by the Drug, Chemical & Associated Technologies Association (DCAT), attracted many biopharmaceutical and upstream and downstream companies to discuss innovation and sustainable development in the industry chain.

DCAT Week, as a highly influential top event in the global pharmaceutical industry, is grandly held annually in New York, USA, attracting over 500 biopharmaceutical and upstream and downstream enterprises to actively participate. This event is organized by the Drug, Chemical & Associated Technologies Association (DCAT), a non-profit global business development association supported by its members. Its unique membership model organically integrates innovative drug and generic drug manufacturers with suppliers and related technologies for ingredients, development, and manufacturing. Many world-leading companies have joined DCAT, providing a wide range of products and services for the entire biopharmaceutical manufacturing industry chain, making DCAT Week an excellent platform for communication and collaboration in the global pharmaceutical industry.

During this conference, Laviana Pharma established a dedicated business space in meeting room 1804 at Hotel 48LEX in downtown New York City, engaging in in-depth discussions with representatives from pharmaceutical companies, technical experts, and investment institutions from North America, Europe, and the Asia-Pacific region. The discussions covered core areas including customized research for small molecule innovative drugs, clinical trial production and commercialization services, as well as customized development and production of innovative pharmaceutical intermediates, and several strategic cooperation intentions were initially reached.

In the future, Laviana Pharma will continue to actively engage in industry events and collaborate with various sectors to enhance its presence on the global pharmaceutical stage, thereby making greater contributions to the pharmaceutical industry. Simultaneously, Laviana Pharma will persist in expanding its business scope by integrating more cutting-edge fields, thus offering more professional and comprehensive services and solutions to pharmaceutical companies across different sectors worldwide.